SYN-002

N/A

Report date: 2026/03/26 20:00:17

Base Information

Drug NameSYN-002
Drug Alias NameSYN-002
ClassificationBiologics > Protein drugs > Recombinant protein > Fusion protein
Mechanisms of ActionCell death stimulantsG-protein coupled receptor homolog US28 inhibitors
TargetsG-protein coupled receptor homolog US28
Therapy Area/IndicationsRejection of renal transplantationCytomegalovirus Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesSynklino ApS
China Registration ClassN/A

Develop Information

Active CompaniesSynklino ApSUniversity Health Network (Uhn)
Inactive CompaniesN/A
Active IndicationsRejection of renal transplantationCytomegalovirus Infections
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A